These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8260526)

  • 41. [Determination by the neutron activation method of the level of stable iodine in the human thyroid gland].
    Mel'nik AD; Risabukhin IuS; Matveenko EG; Vtiurin BM; Shapiro NA
    Med Radiol (Mosk); 1971 Jan; 16(1):12-8. PubMed ID: 5173472
    [No Abstract]   [Full Text] [Related]  

  • 42. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
    Kissonerghis AM; Grubeck-Loebenstein B; Pirich K; Feldmann M; Londei M
    Autoimmunity; 1989; 4(4):255-66. PubMed ID: 2518829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 44. [The expression of G proteins alpha-subunit mRNA in different thyroid diseases].
    Lü ZH; Luo GC; Lu JM; Pan CY
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):103-5. PubMed ID: 12783706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in the acetylcholine concentration and acetylcholinesterase activity in the thyroid gland tissues and in serum cholinesterase activity in goiter].
    Shalaev MI; Elizarovskiĭ GI; Kuteĭnikova AF; Edemskaia EM
    Probl Endokrinol (Mosk); 1977; 23(6):12-4. PubMed ID: 579659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor-2 free from extracellular matrix is increased in papillary thyroid carcinomas and Graves' thyroids.
    Emoto N; Onose H; Sugihara H; Minami S; Shimizu K; Wakabayashi I
    Thyroid; 1998 Jun; 8(6):491-7. PubMed ID: 9669286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma.
    Aanderud S; Matre R; Varhaug JE
    Int Arch Allergy Appl Immunol; 1982; 69(2):137-42. PubMed ID: 6896702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphological demonstration and quantification of TSH binding sites in neoplastic and non-neoplastic thyroid tissues. An autoradiographic study using 125I-labelled thyrotropin.
    Schröder S; Müller-Gärtner HW; Schroiff R; Schmiegelow P; Niendorf A; Böcker W
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):555-70. PubMed ID: 3092456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of the thyroid gland. 10. Iodine content in the surgical material from goiterous thyrid glands in man].
    Kharizanova M; Mitev I; Dishliev B
    Folia Med (Plovdiv); 1970; 12(4):227-32. PubMed ID: 4106425
    [No Abstract]   [Full Text] [Related]  

  • 53. In situ hybridization of the mRNA for interferon-gamma, interferon-alpha E, interferon-beta, interleukin-1 beta and interleukin-6 and characterization of infiltrating cells in thyroid tissues.
    Rutenfranz I; Kruse A; Rink L; Wenzel B; Arnholdt H; Kirchner H
    J Immunol Methods; 1992 Apr; 148(1-2):233-42. PubMed ID: 1532976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro generation of NADPH as an index of thyroid stimulating immunoglobulins (TGI) in goitrous disease.
    McMullan NM; Smyth PP
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):269-80. PubMed ID: 6144407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
    Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves' disease.
    Hsiao PJ; Tsai JH
    J Formos Med Assoc; 1994; 93(11-12):925-32. PubMed ID: 7633196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.
    Lacroix L; Pourcher T; Magnon C; Bellon N; Talbot M; Intaraphairot T; Caillou B; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1423-8. PubMed ID: 15001644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of the thyroid parafollicular (C) cells in simple and hyperactive nodular goitre treated surgically - preliminary investigations.
    Dadan J; Zbucki R RŁ; Sawicki B; Winnicka MM; Puchalski Z
    Folia Morphol (Warsz); 2003 Nov; 62(4):443-5. PubMed ID: 14655137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High incidence of normal thyroid gland volume in patients with Graves' disease.
    Hegedüs L; Hansen JM; Karstrup S
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):603-7. PubMed ID: 6688972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid peroxidation and antioxidants status in human malignant and non-malignant thyroid tumours.
    Stanley JA; Neelamohan R; Suthagar E; Vengatesh G; Jayakumar J; Chandrasekaran M; Banu SK; Aruldhas MM
    Hum Exp Toxicol; 2016 Jun; 35(6):585-97. PubMed ID: 26270564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.